Feature Article

Acne in Skin of Color: Cautions for Chemical Peels


Recent studies suggest that with some caveats, patients with Fitzpatrick skin types IV to VI can achieve satisfactory results without serious adverse effects.

The relative risk for healthcare-associated infections has decreased in the last 15 years due to improvements in awareness of risk associated with devices, infection control, and evidence-based practice regarding use of devices.

Latest News

Acne Relapses Linked to Lower Quality of Life, Productivity

Acne relapses are significantly associated with impaired quality of life as well as productivity loss and absenteeism.

HIDRAdisk Is a Validated Visual Tool to Assess Hidradenitis Suppurativa Burden


Hidradenitis suppurativa has a significant negative impact on patient quality of life, which has been reported to be greater than that of atopic eczema and psoriasis.

New Genetic Mediators Discovered for Predisposition to Acne Vulgaris


The 15 risk loci linked to acne vulgaris in this study account for approximately 3% of phenotypic variance.

Efficacy of Oral Isotretinoin Regimens for Acne Is Inconclusive


Further assessment is needed to determine the efficacy of oral isotretinoin for acne that has not responded to oral antibiotics plus topical agents, as well as different dose/regimens of oral isotretinoin in acne of all severities.

Bermekimab Looks Promising for Hidradenitis Suppurativa


This investigational treatment was evaluated in 42 HS patients, of which 24 had previously failed anti-tumor necrosis factor (TNF) therapy.

Treatment With Microneedle Fractional Radiofrequency System Effective for Acne Scars


The use of microneedle fractional radiofrequency was found to effectively treat facial acne scars in 9 Turkish patients in this retrospective study.

Seysara Now Available for Moderate to Severe Acne Vulgaris


The approval was based on data from 2 large, multicenter, randomized, double-blind, placebo-controlled Phase 3 trials involving patients with moderate to severe acne vulgaris.

Skin Changes, Risk for Severe Acneiform Eruptions Seen With EGFR Inhibitor Therapy


Acneiform eruption caused by treatment with epidermal growth factor receptor (EGFR) inhibitors develops subclinically as early as the first week of the therapy in patients treated with EGFR-tyrosine kinase inhibitor, whereas eruption occurs by the end of the second week in patients treated with an anti-EGFR antibody.

Women See Greater Benefit From Daily Dapsone Gel for Facial Acne


Researchers completed a post hoc analysis of 2 identically designed phase 3 trials to evaluate the efficacy, safety, and tolerability of once-daily dapsone gel, 7.5% when used on facial acne with inflammatory and comedonal lesions.

Clindamycin Monotherapy May Be Superior to Dual Therapy for Hidradenitis Suppurativa


Clindamycin as monotherapy may be a useful and safe alternative to combination clindamycin and rifampicin treatment for hidradenitis suppurativa.

Sign up for Newsletters